Study on the effect of recombinant interferon a 1B in the treatment of bronchial asthma in children

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033379

Enrollment

Unknown

Registered

2020-05-30

Start date

2020-09-01

Completion date

Unknown

Last updated

2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma in children

Interventions

experimental group:Interferon therapy and traditional treatment

Control group:Traditional treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children diagnosed with bronchial asthma in remission are diagnosed according to the Guidelines for the Diagnosis and Prevention of Bronchial Asthma in Children.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

Measure	Time frame
NF-?B;STAT1mRNA;Results of lung function;	—

Countries

China

Contacts

Public ContactZhang Guocheng

Children's Hospital of the Second Affiliated Hospital of Shaanxi University of Chinese Medicine

szl0126@sina.com+86 18622108087

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026